GRM8 and anxiety disorder: WAY-100635 would block post-synaptic 5-HT1A receptor and the increased release of glutamate by BEO could lead to the activation of metabotropic glutamate receptors 8 (mGluR8) involved in anxiety disorders [60,61,62].